Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01588431
Title Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ahmad Wehbe
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Therapy and Research Center at UTHSCSA San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from for the field